Nilotinib therapy after resistance and intolerance to imatinib in CML patient with trisomy of the chromosome 8
In this article is presented the case of a 30-year-old woman with chronic myeloid leukaemia (CML) treated with imatinib for 15 months, and then with nilotinib as second-line therapy. Two episodes of grade 3 neutropenia, the detection of the trisomy of chromosome 8 and the failed achievement of a maj...
में बचाया:
| मुख्य लेखक: | |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
SEEd
2015-10-01
|
| श्रृंखला: | Clinical Management Issues |
| विषय: | |
| ऑनलाइन पहुंच: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1095 |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|